BI-1347

BI-1347
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T5405-1mg 1 mg

7 - 10 business days*

33.00€
TGM-T5405-5mg 5 mg

7 - 10 business days*

76.00€
TGM-T5405-1mL 1 ml

7 - 10 business days*

84.00€
TGM-T5405-10mg 10 mg

7 - 10 business days*

121.00€
TGM-T5405-25mg 25 mg

7 - 10 business days*

238.00€
TGM-T5405-50mg 50 mg

7 - 10 business days*

437.00€
TGM-T5405-100mg 100 mg

7 - 10 business days*

644.00€
TGM-T5405-500mg 500 mg

7 - 10 business days*

1,355.00€
 
Description: BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows... more
Product information "BI-1347"
Description: BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth inhibition in an in vivo xenograft model. Target: CDK. Smiles: CN(C)C(=O)Cn1cc(cn1)-c1ccc(cc1)-c1cncc2ccccc12. References: Harald Engelhardt, et al. New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors.
Supplier: TargetMol
Supplier-Nr: T5405

Properties

MW: 356.42 D
Formula: C22H20N4O

Database Information

CAS : 2163056-91-3| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "BI-1347"
Write a review
or to review a product.
Viewed